Bayer Aktiengesellschaft (ETR:BAYN)

Market Cap	35.25B
Revenue (ttm)	45.87B
Net Income (ttm)	-198.00M
Shares Out	982.42M
EPS (ttm)	-0.20
PE Ratio	n/a
Forward PE	10.30
Dividend	0.11 (0.31%)
Ex-Dividend Date	Apr 28, 2025

Volume	5,740,197
Average Volume	4,209,097
Open	35.50
Previous Close	35.30
Day's Range	35.34 - 35.92
52-Week Range	18.38 - 37.14
Beta	0.83
RSI	68.47
Earnings Date	Feb 25, 2026

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft operates as a life science company worldwide. The company operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women’s health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skin...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1863
• Employees: 91,864
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: BAYN

Financial Performance

In 2024, Bayer Aktiengesellschaft's revenue was 46.61 billion, a decrease of -2.16% compared to the previous year's 47.64 billion. Losses were -2.55 billion, -13.23% less than in 2023.